Project Grant R21AI199648
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $234K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 1, 2026, with a completion date of March 31, 2028. The project, titled "Novel Genetic Approaches to Elucidate Critical Signaling Pathways in Leishmania donovani," will deliver research services focused on identifying essential signaling...
- Federal Grant Award Summary Oregon Health & Science University received a $442,758 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 9, 2026, with completion targeted for January 31, 2028. The project, "Identifying Drug Targets in M. abscessus Through the Application of Fluorescent Probes," aims to elucidate the mechanistic basis of dual B-lactam...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $195,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 6, 2026, with completion targeted for January 31, 2028. The grant funds investigative research examining the intersection of sphingolipid metabolism and innate antiviral immunity, specifically addressing how Type I interferon...
- Federal Grant Award Summary Oregon State University received a $392,747 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 17, 2025, with completion targeted for June 30, 2027. The grant supports research into the biosynthesis and self-resistance mechanisms of kibdelomycin, a natural product antibiotic candidate with a novel binding motif to DNA gyrase. The research...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $482,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026 through January 31, 2028. The award funds preclinical research to develop and evaluate long-acting antiretroviral therapy (LA-ART) as a therapeutic alternative to daily antiretroviral treatment regimens in simian...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $622,130 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 21, 2025, with a completion date of July 31, 2030. The grant funds research investigating bacterial manipulation of atypical ubiquitin signaling, a post-translational modification system that pathogenic bacteria exploit to hijack...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $429,992 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2028. The research project targets T follicular helper (TFH) cell differentiation to enhance antibody responses in infant rhesus macaques following simian-human immunodeficiency virus...
- Federal Project Grant Award Summary Harvard Medical School received a $570,760 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025 through August 31, 2030. The award funds research into the mechanistic and structural features of intraflagellar transport (IFT) in Leishmania parasites, which cause leishmaniasis and related diseases affecting millions...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $3.3 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 21, 2025, with a completion date of June 30, 2029. This grant supports multimodal positron emission tomography (PET) immunoimaging research designed to directly visualize HIV-1 persistence in vivo and identify early tissue foci...
- Federal Project Grant Award Summary Oregon State University received a $408,375 Project Grant award on July 14, 2025, from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on phage-antibiotic combination therapies for treating Mycobacterium abscessus (MAB) infections. The research deliverables focus on identifying and characterizing MAB surface targets involved in phage resistance mechanisms and...